Results 31 to 40 of about 45,169 (292)

Detecting virological failure in HIV-infected Tanzanian children

open access: yesSouth African Medical Journal, 2014
The performance of clinical and immunological criteria to predict virological failure in HIV-infected children receiving antiretroviral therapy (ART) is not well documented.To determine the validity of clinical and immunological monitoring in detecting virological failure in children on ART.A total of 218 children were included in the study.
Mgelea, E M, Kisenge, R, Aboud, S
openaire   +5 more sources

Management of Virologic Failure and HIV Drug Resistance

open access: yesInfectious Disease Clinics of North America, 2019
Approximately 20% of people with HIV in the United States prescribed antiretroviral therapy are not virally suppressed. Thus, optimal management of virologic failure has a critical role in the ability to improve viral suppression rates to improve long-term health outcomes for those infected and to achieve epidemic control.
Suzanne M, McCluskey   +2 more
openaire   +3 more sources

Benefit of viral load testing for confirmation of immunological failure in HIV patients treated in rural Malawi. [PDF]

open access: yes, 2011
Objective  Viral load testing is used in the HIV programme of Chiradzulu, Malawi, to confirm the diagnosis of immunological failure to prevent unnecessary switching to second-line therapy.
Badri   +14 more
core   +2 more sources

Magnitude and Determinants of Virological Failure Among Patients >15 Years on Anti-Retroviral Therapy in Rural Lesotho Between 2015 and 2019 – A Retrospective Cohort Study

open access: yesHIV/AIDS: Research and Palliative Care, 2023
Thabo Ishmael Lejone,1,2 Ozayr Mahomed1 1SolidarMed, Lesotho, South Africa; 2Discipline of Public Health Medicine, University of KwaZulu Natal, Durban, South AfricaCorrespondence: Ozayr Mahomed, Howard College, University of KwaZulu Natal, 227 George ...
Lejone TI, Mahomed O
doaj  

Viral Load Monitoring of Antiretroviral Therapy, cohort viral load and HIV transmission in Southern Africa: A Mathematical Modelling Analysis [PDF]

open access: yes, 2012
In low-income settings, treatment failure is often identified using CD4 cell count monitoring. Consequently, patients remain on a failing regimen, resulting in a higher risk of transmission.
Attia   +30 more
core   +2 more sources

Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study

open access: yesBMC Infectious Diseases, 2020
Background Although the United Nations program on HIV/AIDS 90–90-90-targets recommends achieving 90% of viral suppression for patients on first-line antiretroviral therapy by 2020, virological failure is still high and it remains a global public health ...
Chilot Desta Agegnehu   +2 more
doaj   +1 more source

Virological Failure After Switch to Long-Acting Cabotegravir and Rilpivirine Injectable Therapy: An In-depth Analysis. [PDF]

open access: yesClin Infect Dis
van Welzen BJ   +10 more
europepmc   +2 more sources

Adherence to Antiretroviral Therapy and Virologic Failure

open access: yesMedicine, 2016
The often cited need to achieve ≥95% (nearly perfect) adherence to antiretroviral therapy (ART) for successful virologic outcomes in HIV may present a barrier to initiation of therapy in the early stages of HIV. This meta-analysis synthesized 43 studies (27,905 participants) performed across >26 countries, to determine the relationship between cut-off ...
Bezabhe, Woldesellassie M.   +3 more
openaire   +2 more sources

NAFLD‐related hepatocellular carcinoma: The growing challenge

open access: yesHepatology, EarlyView., 2022
Risk and protective factors for NAFLD‐related hepatocellular carcinoma Abstract Hepatocellular carcinoma (HCC) is a common cause of cancer‐related mortality and morbidity worldwide. With the obesity pandemic, NAFLD‐related HCC is contributing to the burden of disease exponentially.
Pir Ahmad Shah   +2 more
wiley   +1 more source

Positive Outcomes of HAART at 24 Months in HIV-Infected Patients in Cambodia. [PDF]

open access: yes, 2007
OBJECTIVES: African and Asian cohort studies have demonstrated the feasibility and efficacy of HAART in resource-poor settings. The long-term virological outcome and clinico-immunological criteria of success remain important questions.
Bartlett   +35 more
core   +2 more sources

Home - About - Disclaimer - Privacy